化学
碳酸酐酶
一氧化氮
生物化学
癌症
酶
组合化学
药理学
有机化学
内科学
医学
作者
Silvia Bua,Alessio Nocentini,Alessandro Bonardi,Giuseppe Palma,Giulia Ciampi,Angela Giliberti,Federica Iannelli,Francesca Bruzzese,Claudiu Trandafir Supuran,Filomena de Nigris
标识
DOI:10.1021/acs.jmedchem.4c01563
摘要
We describe here the design and antitumor evaluation of benzofuroxan-based nitric oxide (NO)-donor hybrid derivatives targeting human carbonic anhydrases (hCAs) IX and XII. The most effective compounds, 27 and 28, demonstrated potent dual action, exhibiting low nanomolar inhibition constants against hCA IX and significant NO release. Notably, compound 27 showed significant antiproliferative effects against various cancer cell lines, particularly renal carcinoma A-498 cells. In these cells, it significantly reduced the expression of CA IX and iron-regulatory proteins, inducing apoptosis via mitochondrial caspase activity and ferroptosis pathways, as evidenced by increases in ROS, nitrite, and down-regulated expression of ferritin-encoding genes. In three-dimensional tumor models, compound 27 effectively reduced spheroid size and viability. In vivo toxicity studies in mice indicated that the compounds were well-tolerated, with no significant alterations in kidney function. These findings underscore the potential of benzofuroxan-based CA inhibitors for further preclinical evaluations as therapeutic agents targeting renal cell carcinoma.
科研通智能强力驱动
Strongly Powered by AbleSci AI